The interactive effects of JUUL flavor and nicotine concentration on addiction potential.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Peasley-Miklus (2023)
Vaping-Related adverse Events and Perceived health Improvements: a Cross-Sectional Survey among Daily E-Cigarette Users.
Individual Clinical
Safety
Adverse Effects
Pénzes (2021)
association between Electronic Cigarette Use and asthma in Never-Smokers.
Individual Clinical
Safety
Adverse Effects
Perez (2019)
Biomarkers of Toxicant Exposure and Inflammation among Women of Reproductive age Who Use Electronic or Conventional Cigarettes.
Individual Clinical
Biomarkers
Biomarkers Of Harm
Perez (2021)
The inflammatory biomarker YKL-40 is elevated in the serum, but not the sputum, of E-cigarette users.
Individual Clinical
Biomarkers
Biomarkers Of Harm
Perez (2021)
Transcriptomic responses in the blood and sputum of cigarette smokers compared to e-cigarette vapers.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Perez (2023)
E-cigarette promotes breast carcinoma progression and lung metastasis: Macrophage-tumor cells crosstalk and the role of CCL5 and VCaM-1.
Individual Clinical
Safety
Adverse Effects
Pham (2020)
Nicotine delivery and user reactions to Juul EU (20 mg/ml) compared with Juul US (59 mg/ml), cigarettes and other e-cigarette products.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Phillips-Waller (2021)
Use of E-cigarettes and Other Tobacco Products and Progression to Daily Cigarette Smoking.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Pierce (2021)
E-Cigarette-associated Endothelial Damage: a Potential Mechanism for Erectile Dysfunction.
Individual Clinical
Safety
Adverse Effects
Pincus (2022)